Results 321 to 330 of about 171,326 (357)

Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised trials

Lancet, The, 2023
exaly  

[Intravenous immunoglobulin therapy].

La Revue du praticien, 2005
Intravenous immunoglobulins (IVIg) are therapeutic preparations of normal human IgG that are obtained from pools of healthy blood donors. They can be used at low dose in the substitutive therapy of patients with primary or secondary immune deficiencies, or at high dose as an immunomodulatory agent in a large number of autoimmune and/or systemic ...
openaire   +1 more source

Intravenous immunoglobulins

Transfusion Science, 1992
openaire   +1 more source

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

Lancet, The, 2010
Rüdiger von Kummer, Danilo S Toni, James C Grotta   +2 more
exaly  

Intravenous Immunoglobulin

1989
A. C. Newland, P. A. Veys
openaire   +1 more source

Intravenous versus subcutaneous immunoglobulin

The Lancet Neurology, 2018
Ravi, Uniyal, Ravindra Kumar, Garg, Hardeep Singh, Malhotra, Neeraj, Kumar, Shweta, Pandey   +4 more
openaire   +2 more sources

Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke

New England Journal of Medicine, 2015
Jeffrey L. Saver, Mayank Goyal, Alain Bonafe   +2 more
exaly  

Oral versus Intravenous Antibiotics for Bone and Joint Infection

New England Journal of Medicine, 2019
Ines Rombach, Rhea Zambellas, Martin A Mcnally   +2 more
exaly  

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Lancet, The, 2022
exaly  

Intravenous Immunoglobulin

2007
openaire   +1 more source